|
Flavanones
|
D044950 |
[A group of FLAVONOIDS characterized with a 4-ketone.
] |
|
Fibrinolysis
|
D005342 |
[The natural enzymatic dissolution of FIBRIN.
] |
|
Lewy Body Disease
|
D020961 |
[A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
] |
|
Fibrinolytic Agents
|
D005343 |
[Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
] |
|
Heterotrimeric GTP-Binding Proteins
|
D020962 |
[GTP-BINDING PROTEINS that contain three non-identical subunits. They are found associated with members of the seven transmembrane domain superfamily of G-PROTEIN-COUPLED RECEPTORS. Upon activation the GTP-BINDING PROTEIN ALPHA SUBUNIT of the complex dissociates leaving a dimer of a GTP-BINDING PROTEIN BETA SUBUNIT bound to a GTP-BINDING PROTEIN GAMMA SUBUNIT.
] |
|
Fibrinopeptide A
|
D005344 |
[Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin.
] |
|
Fibrinopeptide B
|
D005345 |
[Two small peptide chains removed from the N-terminal segment of the beta chains of fibrinogen by the action of thrombin. Each peptide chain contains 20 amino acid residues. The removal of fibrinopeptides B is not required for coagulation.
] |
|
omega-Conotoxins
|
D020960 |
[A family of structurally related neurotoxic peptides from mollusk venom that inhibit voltage-activated entry of calcium into the presynaptic membrane. They selectively inhibit N-, P-, and Q-type calcium channels.
] |
|
Fibroma
|
D005350 |
[A benign tumor of fibrous or fully developed connective tissue.
] |
|
Protein Kinase Inhibitors
|
D27.505.519.389.755 |
|
|
Fibromatosis, Gingival
|
D005351 |
[Generalized or localized diffuse fibrous overgrowth of the gingival tissue, usually transmitted as an autosomal dominant trait, but some cases are idiopathic and others produced by drugs. The enlarged gingiva is pink, firm, and has a leather-like consistency with a minutely pebbled surface and in severe cases the teeth are almost completely covered and the enlargement projects into the oral vestibule. (Dorland, 28th ed)
] |
|
Fibromuscular Dysplasia
|
D005352 |
[An idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to STENOSIS of small and medium-sized arteries. There is true proliferation of SMOOTH MUSCLE CELLS and fibrous tissue. Fibromuscular dysplasia lesions are smooth stenosis and occur most often in the renal and carotid arteries. They may also occur in other peripheral arteries of the extremity.
] |
|
Secretin
|
D06.472.699.810 |
|
|
Disease Attributes
|
D020969 |
[Clinical characteristics of disease or illness.
] |
|
Myotonic Disorders
|
D020967 |
[Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition.
] |
|
Brachial Plexus Neuritis
|
D020968 |
[A syndrome associated with inflammation of the BRACHIAL PLEXUS. Clinical features include severe pain in the shoulder region which may be accompanied by MUSCLE WEAKNESS and loss of sensation in the upper extremity. This condition may be associated with VIRUS DISEASES; IMMUNIZATION; SURGERY; heroin use (see HEROIN DEPENDENCE); and other conditions. The term brachial neuralgia generally refers to pain associated with brachial plexus injury. (From Adams et al., Principles of Neurology, 6th ed, pp1355-6)
] |
|
Visually Impaired Persons
|
D019987 |
[Persons with loss of vision such that there is an impact on activities of daily living.
] |
|
Organ Motion
|
G11.427.410.849 |
|
|
Movement
|
G11.427.410 |
|
|
Avihepadnavirus
|
B04.450.390.100 |
|
